NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-321-2003-0-LU-24 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 LU EP 04814140.2 Issued
NCI E-321-2003-0-NL-25 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 NL EP 04814140.2 Issued
NCI E-321-2003-0-IE-22 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 IE EP 04814140.2 Issued
NCI E-321-2003-0-GR-21 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 GR EP 04814140.2 Issued
NCI E-321-2003-0-IT-23 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 IT EP 04814140.2 Issued
NCI E-321-2003-0-EP-04 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 EP National Stage 04814140.2 Issued
NCI E-321-2003-0-FR-19 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 FR EP 04814140.2 Issued
NCI E-321-2003-0-FI-18 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 FI EP 04814140.2 Issued
NCI E-321-2003-0-DE-15 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 DE EP 04814140.2 Issued
NCI E-321-2003-0-SE-27 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 SE EP 04814140.2 Issued
NCI E-321-2003-0-NO-26 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 NO EP 04814140.2 Issued
NCI E-321-2003-0-ES-17 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 ES EP 04814140.2 Issued
NCI E-321-2003-0-CA-07 Human Cytotoxic T-lymphocyte Epitope And Its Agonist Epitope From the Non-Variable Number Of Tandem Repeat Sequence Of MUC-1 CA National Stage 2547635 Issued
NCI E-321-2003-0-JP-05 A Human Cytoxic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 JP National Stage 2006-544119 Issued
NCI E-321-2003-0-AU-06 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 AU National Stage 2004299457 Issued
NCI E-274-2003-0-PCT-02 2-Amino-O4-Substituted Pteridines and Their Use as Inactivators of O6-Alkulguanine-DNA Alkyltransferase PCT PCT PCT/US2004/41577 Expired
NCI E-321-2003-0-PCT-02 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 PCT PCT PCT/US2004/041921 Expired
NCI E-274-2003-0-EP-04 2-Amino-O4-Substituted Pteridines and Their Use as Inactivators of O6-Alkulguanine-DNA Alkyltransferase EP National Stage 04813836.6 Abandoned
NCI E-321-2003-0-AU-09 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 AU DIV 2011203056 Abandoned
NCI E-274-2003-0-AU-06 2-Amino-O4-Substituted Pteridines and Their Use as Inactivators of O6-Alkulguanine-DNA Alkyltransferase AU National Stage 2004313931 Abandoned
NCI E-274-2003-0-CA-05 2-Amino-O4-Substituted Pteridines and Their Use as Inactivators of O6-Alkulguanine-DNA Alkyltransferase CA National Stage 2552826 Abandoned
NHLBI E-259-2003-0-AU-04 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder AU National Stage 2004296868 Abandoned
NIAID E-232-2004-2-US-08 Compositions And Methods For Generating An Immune Response US CON 11/009,063 7795017 Expired PDF
NHLBI E-259-2003-0-ZA-14 METHOD FOR SUPPRESSING AN IMMUNE RESPONSE OR TREATING A PROLIFERATIVE DISORDER ZA National Stage 2006/04724 Abandoned
NHLBI E-259-2003-0-ES-25 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder ES EP 04813574.3 Abandoned
NHLBI E-259-2003-0-EP-03 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder EP National Stage 04813574.3 Abandoned
NHLBI E-259-2003-0-GB-23 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder GB EP 04813574.3 Abandoned
NHLBI E-259-2003-0-DE-21 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder DE EP 04813574.3 Abandoned
NHLBI E-259-2003-0-FR-22 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder FR EP 04813574.3 Abandoned
NHLBI E-259-2003-0-IT-24 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder IT EP 04813574.3 Abandoned
NCI E-265-2003-0-PCT-02 Methods For Inhibitors Of HIV And Other Viral Infection By Modulators Of Ceramide Metabolism PCT PCT PCT/US2004/41512 Expired
NHLBI E-259-2003-0-PCT-02 METHOD FOR SUPPRESSING AN IMMUNE RESPONSE OR TREATING A PROLIFERATIVE DISORDER PCT PCT PCT/US2004/041265 Expired
NHLBI E-259-2003-0-MX-15 Methods for Suppressing an Immune Response or Treating a Profliferative Disorder MX National Stage PA/a/2006/006651 Abandoned
NHLBI E-259-2003-0-JP-06 Methods for Suppressing and Immune Response or Treating a Proliferative Disorder JP National Stage 2006-543983 Abandoned
NHLBI E-259-2003-0-KR-16 METHOD FOR SUPPRESSING AN IMMUNE RESPONSE OR TREATING A PROLIFERATIVE DISORDER KR National Stage 10-2006-7013786 Abandoned
NHLBI E-259-2003-0-RU-13 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder RU National Stage 2006124421 Abandoned
NCI E-045-2004-1-US-01 CD4+ Cell Activation And Death Markers For Evaluating Reagents That Block The Binding Of HIV-1 To CD4+ Cells Resulting In CD4+ T Cell Depletion US 60/634,255 Abandoned
NIMH E-184-2004-0-US-01 A Novel Amplification Method Permits Pathogens To Be Detected With Microarrays. US 60/635,239 Abandoned
NHLBI E-259-2003-0-BR-09 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder BR National Stage PI0417498-4 Abandoned
NHLBI E-259-2003-0-IN-10 METHODS FOR SUPPRESSING AN IMMUNE RESPONSE OR TREATING A PROLIFERATIVE DISORDER. IN National Stage 3448/DELNP/2006 Abandoned
NHLBI E-259-2003-0-IL-11 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder IL National Stage 176214 Abandoned
NHLBI E-259-2003-0-EG-18 Methods for suppressing an immune response or treating a proliferative disorder EG National Stage PCT/NA/534/2006 Abandoned
NHLBI E-259-2003-0-CA-05 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder CA National Stage 2546920 Abandoned
NHLBI E-259-2003-0-TR-19 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder TR DIV 2008/08208 Abandoned
NHLBI E-259-2003-0-TR-17 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder TR National Stage 2006/04485 Abandoned
NIDDK E-096-2002-0-US-06 An Obligate Domain-Swapped Dimer of Cyanovirin With Enhanced Anti-Viral Activity US National Stage 10/505,666 7276227 Abandoned PDF
NCI E-052-2002-0-US-03 TUMOR SUPPRESSOR GENE POLYPEPTIDES AND RELATED NUCLEIC ACIDS, HOST CELLS, COMPOSITIONS, AND METHODS OF USE IN INHIBITION OF CELL GROWTH, MODULATION OF GENE EXPRESSION, AND ENHANCEMENT OF IMMUNE-RESPONSE INDUCING EFFECT OF A VACCINE US National Stage 10/513,114 Abandoned
NCI E-087-1996-0-US-06 HETEROLOGOUS BOOSTING IMMUNIZATIONS US CON 11/007,115 Abandoned
NIEHS E-237-1994-1-JP-32 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE JP DIV 2004-355724 Expired
NHLBI E-160-2002-0-US-03 Tryptophan as a Functional Replacement for ADP-ribose-arginine in Recombinant Proteins US National Stage 10/517,565 7541139 Expired PDF